Cardinal Health, Inc. CAH
Set alert
At close · Nov 2
After hours · Nov 2, 6:36 PM ET
- YTD
- +23.76%
- 1 year
- +33.32%
- Open
- 251.48
- Prev close
- 250.48
- Mkt cap
- 58.89B
- Vol
- 1.90M
- Avg vol
- 1.78M
- EPS
- 7.34
- P/E
- 34.65
- Div yield
- 0.82%
More statistics
- Low
- 248.90
- High
- 255.23
- Forward P/E
- 18.09
- Beta
- 0.52
- Short ratio
- 4.16
- Inst. own
- 91.46%
- Dividend
- 2.06
- Ex-div date
- Sep 30, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 237.78
- 200-d avg
- 222.15
- 1y target
- 273.47
5Y chart
Events in this range
- Dec 31, 2021Dividend: 0.491
- Mar 31, 2022Dividend: 0.491
- Jun 30, 2022Dividend: 0.496
- Sep 30, 2022Dividend: 0.496
- Dec 30, 2022Dividend: 0.4957
- Jan 15, 2023Dividend: 0.496
- Mar 31, 2023Dividend: 0.4957
- Jun 30, 2023Dividend: 0.5006
- Oct 2, 2023Dividend: 0.5006
- Dec 29, 2023Dividend: 0.5006
- Mar 28, 2024Dividend: 0.5006
- Jun 30, 2024Dividend: 0.5056
- Jul 1, 2024Dividend: 0.5056
- Oct 1, 2024Dividend: 0.5056
- Jan 2, 2025Dividend: 0.5056
- Apr 1, 2025Dividend: 0.5056
- Jul 1, 2025Dividend: 0.5107
- Aug 12, 2025Earnings: 2.08; estimate 2.04; surprise 1.96%
- Oct 1, 2025Dividend: 0.5107
- Oct 30, 2025Earnings: 2.55; estimate 2.18; surprise 16.97%
- Jan 2, 2026Dividend: 0.5107
- Feb 5, 2026Earnings: 2.63; estimate 2.34; surprise 12.39%
- Apr 1, 2026Dividend: 0.5107
- Apr 30, 2026Earnings: 3.17; estimate 2.79; surprise 13.62%
- Jul 1, 2026Dividend: 0.5158
- Aug 11, 2026Earnings: 2.91; estimate 2.42; surprise 20.25%
- Aug 13, 2026Rating: JP Morgan · Neutral → Neutral
- Aug 13, 2026Rating: TD Cowen · Buy → Buy
- Aug 19, 2026Rating: RBC Capital · — → Outperform
- Oct 1, 2026Dividend: 0.5158
- Oct 16, 2026Rating: UBS · Buy → Buy
- Oct 20, 2026Rating: Mizuho · Outperform → Outperform
- Oct 30, 2026Rating: Morgan Stanley · Overweight → Overweight
- Nov 5, 2026Earnings: —; estimate 2.94; surprise —%
Signals (80)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| RSI: Overbought | Feb 16, 2026 | 8 months ago |
| RSI: Overbought | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| RSI: Overbought | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Oct 27, 2025 | 1 year ago |
| RSI: Overbought | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
Newest 20 of 80.
Key statistics
- Market cap
- 58.90B
- Enterprise value
- 63.56B
- Trailing P/E
- 35.18
- Forward P/E
- 18.09
- PEG ratio
- 1.25
- Price / sales
- 0.23
- Price / book
- 0.00
- EPS (TTM)
- 7.23
- Beta
- 0.52
- Dividend yield
- 0.82%
- Payout ratio
- 28.33%
- Profit margin
- 0.67%
- Revenue (TTM)
- 254.25B
- Revenue growth
- 5.80%
- Free cash flow
- 4.75B
- Total cash
- 4.86B
- Total debt
- 10.00B
- Return on equity
- 0.00%
- Shares outstanding
- 231.56M
- Short % of float
- 3.32%
- 50-day average
- 237.78
- 200-day average
- 222.15
Analyst view
Consensus: buy
- Target (low)
- 235.00
- Target (mean)
- 273.47
- Target (high)
- 295.00
- Strong buy3
- Buy11
- Hold3
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 2.94.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 2.94 | — | — | — |
| Aug 11, 2026 | Jun 30, 2026 | 2.42 | 2.91 | +0.49 | +20.25% |
| Apr 30, 2026 | Mar 31, 2026 | 2.79 | 3.17 | +0.38 | +13.62% |
| Feb 5, 2026 | Dec 31, 2025 | 2.34 | 2.63 | +0.29 | +12.39% |
| Oct 30, 2025 | Sep 30, 2025 | 2.18 | 2.55 | +0.37 | +16.97% |
| Aug 12, 2025 | Jun 30, 2025 | 2.04 | 2.08 | +0.04 | +1.96% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Morgan Stanley | main | Overweight | Overweight |
| Oct 20, 2026 | Mizuho | main | Outperform | Outperform |
| Oct 16, 2026 | UBS | main | Buy | Buy |
| Aug 19, 2026 | RBC Capital | init | — | Outperform |
| Aug 13, 2026 | TD Cowen | main | Buy | Buy |
| Aug 13, 2026 | JP Morgan | main | Neutral | Neutral |
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Country
- United States
- Website
- cardinalhealth.com
News
- What Analyst Projections for Key Metrics Reveal About Cardinal (CAH) Q1 Earnings
- Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?
- Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $286
- Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
- The Dividend Aristocrats Ranked By Quality Scores (October 2026)
- Cardinal Health (CAH) Laps the Stock Market: Here's Why
- Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280
- UBS Maintains Buy on Cardinal Health, Raises Price Target to $295
- Cardinal Health (CAH) Laps the Stock Market: Here's Why
- 3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
Your note
Sign in to keep a note on CAH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALT AARON E. | Chief Financial Officer | Sale | Aug 17, 2026 | 20,495 |
| HALL PATRICIA HEMINGWAY | Director | Stock Award(Grant) | Apr 14, 2026 | 28,645 |
| HOLLAR JASON M | Chief Executive Officer | Sale | Aug 18, 2026 | 190,603 |
| JOHRI AKHIL | Director | Stock Award(Grant) | Nov 4, 2025 | 22,868 |
| KENNY GREGORY B | Director | Stock Award(Grant) | Nov 4, 2025 | 64,194 |
| KILLEFER NANCY | Director | Stock Award(Grant) | Nov 4, 2025 | 27,624 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.44% | 26,490,633 | 6.74B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.60% | 15,292,186 | 3.89B | Jun 29, 2026 |
| Wellington Management Group, LLP | 6.42% | 14,860,271 | 3.78B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.92% | 13,717,894 | 3.49B | Jun 29, 2026 |
| State Street Corporation | 5.17% | 11,967,121 | 3.04B | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.80% | 6,472,810 | 1.65B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.21% | 7,434,902 | 1.89B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.62% | 6,067,518 | 1.54B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.19% | 5,074,708 | 1.29B | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.34% | 3,099,179 | 788.26M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.31% | 3,040,204 | 773.26M | Aug 30, 2026 |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1.24% | 2,870,270 | 730.04M | Sep 29, 2026 |
